Related Experiment Videos
[CD4+, CD25+ regulatory T-lymphocytes: current concepts and therapeutic potential]
1Laboratoire de Biologie et Thérapeutique des Pathologies Immunitaires. CNRS UMR 7087, CERVI, Hôpital de la Pitié-Salpêtrière, Bd de l'hôpital, 75651, Paris.
Journal De La Societe De Biologie
|March 21, 2003
Summary
Regulatory CD4+CD25+ T cells, originating in the thymus, suppress immune responses. These auto-reactive cells show promise for treating autoimmune diseases and preventing transplant rejection.
Area of Science:
- Immunology
- Cell Biology
- Autoimmunity
Context:
- CD4 T cells are crucial immune regulators.
- A specific subset, CD4+CD25+ T cells, constitutively expresses CD25.
- These cells are implicated in the pathogenesis of autoimmune diseases.
Purpose:
- To investigate the regulatory mechanisms of CD4+CD25+ T cells.
- To explore the therapeutic potential of CD4+CD25+ T cells.
Summary:
- CD4+CD25+ T cells, with thymic origin and auto-reactive properties, inhibit conventional CD4+ and CD8+ T cell activation.
- Their constitutive CD25 expression marks them as key regulators in immune responses.
Impact:
- CD4+CD25+ T cells offer therapeutic potential for autoimmune diseases.
- These cells may also be utilized to manage allograft rejection and graft-versus-host disease.